RPG Life Sciences Share Price
RPG Life Sciences Share Price Today
As of 6 Jul 2026, RPG Life Sciences share price is ₹2,450.00. The stock opened at ₹2,415.80, compared to its previous close of ₹2,415.80. During today's trading session, RPG Life Sciences share price moved in the range of ₹2,385.80 to ₹2,479.20, with an average price of ₹2,432.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,733.00 and a high of ₹2,725.00. On the performance front, RPG Life Sciences share price has increased by 4.03% over the last six months and is down 4.10% on a year-on-year basis.
RPG Life Sciences Returns Calculator
RPG Life Sciences Shareholder Returns
RPG Life Sciences Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,56,989.00 | 39.71 | 5.47 | 13.74% | 0.61 | 17.33% | 93.24 | 0.84% | 0.56 | 10.90 |
| Divis Laboratories | 1,79,471.00 | 69.89 | 10.71 | 15.32% | 0.00 | 19.56% | 629.49 | 0.44% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,61,290.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,820.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Zydus Lifesciences | 1,14,811.00 | 22.41 | 4.23 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Dr. Reddy's Laboratories | 1,14,730.00 | 24.97 | 2.75 | 11.64% | 0.15 | 13.65% | 3.32 | 0.64% | 0.63 | 38.68 |
| Lupin | 1,13,215.00 | 21.14 | 5.04 | 23.76% | 0.04 | 24.88% | 659.05 | 0.73% | 0.61 | 129.18 |
| Mankind Pharma | 1,04,535.00 | 53.93 | 6.41 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 94,095.70 | 26.86 | 2.48 | 9.25% | 0.19 | 11.76% | 391.14 | 0.25% | 0.48 | 41.58 |
| Laurus Labs | 83,293.00 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
RPG Life Sciences Financials
Income Statement · Consolidated
| Particulars | Mar 2026 | Mar 2025 |
|---|---|---|
| Revenue | ₹707.52 | ₹653.43 |
| Other Income | ₹25.58 | ₹12.68 |
| Total Revenue | ₹733.10 | ₹666.11 |
| Total Expenses | ₹582.80 | ₹515.83 |
| Profit Before Tax | ₹154.20 | ₹232.88 |
| Tax | ₹39.03 | ₹49.64 |
| Profit After Tax | ₹115.17 | ₹183.24 |
| EPS - Basic | ₹69.64 | ₹110.80 |
| EPS - Diluted | ₹69.64 | ₹110.80 |
Cash Flow · Consolidated
| Particulars | Mar 2026 | Mar 2025 |
|---|---|---|
| Profit before tax | ₹154.20 | ₹232.88 |
| Income before WC changes | ₹136.89 | ₹156.66 |
| Change in Assets | -₹76.45 | -₹24.20 |
| Change in Liabilities | ₹33.28 | -₹1.85 |
| Change in WC | -₹43.17 | -₹26.05 |
| Cash flow from Operations | ₹56.50 | ₹77.86 |
| Cash flow from Investing | ₹85.84 | -₹41.80 |
| Cash flow from Financing | -₹20.58 | -₹27.08 |
| Total Cash Flow | ₹121.76 | ₹8.98 |
| Cash (Start of the year) | ₹28.70 | ₹19.72 |
| Cash (End of the year) | ₹150.46 | ₹28.70 |
Balance Sheet · Consolidated
| Particulars | Mar 2026 | Mar 2025 |
|---|---|---|
| Non-Current Assets | ₹233.68 | ₹192.56 |
| Current Assets | ₹559.48 | ₹465.25 |
| Total Assets | ₹793.16 | ₹657.81 |
| Current Liabilities | ₹160.57 | ₹119.83 |
| Net Current Asset | ₹398.91 | ₹345.42 |
| Non-Current Liabilities | ₹27.24 | ₹7.45 |
| Equity Capital | ₹605.35 | ₹530.53 |
| Total Equity & Liabilities | ₹793.16 | ₹657.81 |
Income Statement · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | ₹707.52 | ₹653.43 | ₹582.05 | ₹512.81 |
| Other Income | ₹25.54 | ₹12.68 | ₹7.21 | ₹4.80 |
| Total Revenue | ₹733.06 | ₹666.11 | ₹589.26 | ₹517.61 |
| Total Expenses | ₹582.76 | ₹515.83 | ₹471.42 | ₹425.93 |
| Profit Before Tax | ₹154.20 | ₹232.88 | ₹117.84 | ₹91.68 |
| Tax | ₹39.03 | ₹49.64 | ₹30.18 | ₹24.04 |
| Profit After Tax | ₹115.17 | ₹183.24 | ₹87.66 | ₹67.64 |
| EPS - Basic | ₹69.64 | ₹110.80 | ₹53.01 | ₹40.90 |
| EPS - Diluted | ₹69.64 | ₹110.80 | ₹53.01 | ₹40.90 |
Cash Flow · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Profit before tax | ₹154.20 | ₹232.88 | ₹117.84 | ₹91.68 |
| Income before WC changes | ₹136.89 | ₹156.66 | ₹130.76 | ₹104.99 |
| Change in Assets | -₹76.44 | -₹24.20 | -₹25.44 | -₹12.96 |
| Change in Liabilities | ₹33.26 | -₹1.85 | ₹18.35 | ₹24.02 |
| Change in WC | -₹43.18 | -₹26.05 | -₹7.09 | ₹11.06 |
| Cash flow from Operations | ₹56.50 | ₹77.86 | ₹94.36 | ₹90.82 |
| Cash flow from Investing | ₹51.06 | -₹41.80 | -₹79.15 | -₹105.81 |
| Cash flow from Financing | -₹20.58 | -₹27.08 | -₹20.31 | -₹17.12 |
| Total Cash Flow | ₹86.98 | ₹8.98 | -₹5.10 | -₹32.11 |
| Cash (Start of the year) | ₹28.70 | ₹19.72 | ₹24.82 | ₹56.94 |
| Cash (End of the year) | ₹115.68 | ₹28.70 | ₹19.72 | ₹24.83 |
Balance Sheet · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Non-Current Assets | ₹268.45 | ₹192.56 | ₹214.78 | ₹155.30 |
| Current Assets | ₹524.69 | ₹465.25 | ₹298.09 | ₹264.05 |
| Total Assets | ₹793.14 | ₹657.81 | ₹512.87 | ₹419.35 |
| Current Liabilities | ₹160.53 | ₹119.83 | ₹130.96 | ₹102.78 |
| Net Current Asset | ₹364.16 | ₹345.42 | ₹167.13 | ₹161.27 |
| Non-Current Liabilities | ₹27.24 | ₹7.45 | ₹7.06 | ₹8.97 |
| Equity Capital | ₹605.37 | ₹530.53 | ₹374.85 | ₹307.60 |
| Total Equity & Liabilities | ₹793.14 | ₹657.81 | ₹512.87 | ₹419.35 |
About RPG Life Sciences
RPG Life Sciences Limited is an India-based research-based pharmaceutical company. The Company operates in the domestic and international markets in the formulations, generics, and synthetic active pharmaceutical ingredients (APIs) space. Its business portfolio includes domestic formulations, international formulations, and APIs. Its domestic formulation business manufactures and markets branded finished dosage formulations in India. The domestic formulations business has a presence in nephrology, oncology, rheumatology, cardiology, respiratory, pain management, vitamins & minerals, gastroenterology, and gynecology & pediatrics. The International Formulations business operates in the generics and branded generics space across Canada, Europe, Australia, New Zealand, and South America. Its products include Azoran, Mofetyl, Arpimune ME, Azathioprine, Quinfamide, Nicorandil, Haloperidol, Risperidone, Tolvaptan, Spironolactone, Sertraline, Naprosyn, Teristrong, and others.
RPG Life Sciences Financial Highlights
- Revenue: RPG Life Sciences reported revenue of ₹733.10 crore in FY26 vs ₹666.11 crore in FY25. It showed an increase of 10.06% on a yearly basis.
- Operating Profit: RPG Life Sciences reported an operating profit of ₹154.20 crore in FY26 vs ₹232.88 crore in FY25. It showed a decrease of 33.79% on a year-on-year basis.
- Net Profit: RPG Life Sciences reported a net profit of ₹115.17 crore in FY26 vs ₹183.24 crore in FY25. It showed a decrease of 37.15% on a yearly basis.
RPG Life Sciences Quarterly Result Highlights
- RPG Life Sciences reported revenue of ₹189.29 crore in Mar 2026, compared with ₹183.44 crore in Dec 2025, representing an increase of 3.19% on a quarter-on-quarter (QoQ) basis.
- RPG Life Sciences reported an operating profit of ₹40.20 crore in Mar 2026, compared with ₹29.12 crore in Dec 2025, representing an increase of 38.05% on a quarter-on-quarter (QoQ) basis.
- RPG Life Sciences reported a profit of ₹29.90 crore in Mar 2026, compared with ₹22.13 crore in Dec 2025, reflecting an increase of 35.11% on a QoQ basis.
- The earnings per share (EPS) of RPG Life Sciences stood at ₹69.64 during Mar 2026.
Similar Stocks
FAQs on RPG Life Sciences Share Price
What is RPG Life Sciences share price today?
RPG Life Sciences share price is ₹2,450.00 as on 06 Jul, 2026, 15:29 IST.
How has the RPG Life Sciences share price performed in the past?
In the last 1 year, RPG Life Sciences delivered a return of -4.10%. The RPG Life Sciences share price hit a high of ₹2,725.00 and low of ₹1,733.00.
How much is the Mutual Fund shareholding in RPG Life Sciences shares?
The Mutual Fund Shareholding in RPG Life Sciences was 0.04% at the end of Mar 2026.
What is the the 52-week high and low of RPG Life Sciences shares ?
The 52-week high and low of RPG Life Sciences share is ₹2,725.00 and ₹1,733.00 as of 06 Jul, 2026.
What is the market cap of RPG Life Sciences?
The market capitalisation of RPG Life Sciences is ₹3,996.90 Crores as on 06 Jul, 2026.
What are the stock symbols of RPG Life Sciences?
The stock symbol of RPG Life Sciences is RPGLIFE on the NSE, 532983 on the BSE, and the ISIN is INE105J01010.
What was yesterday's closing price of RPG Life Sciences shares ?
RPG Life Sciences shares closed yesterday at ₹2,415.80 on NSE & ₹2,416.65 on BSE
How to buy RPG Life Sciences shares?
To buy RPG Life Sciences shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy RPG Life Sciences shares on Holidays?
No, shares of RPG Life Sciences or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell RPG Life Sciences shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of RPG Life Sciences?
The PE and PB ratio of RPG Life Sciences is 26.57 and 5.05 respectively, as on 06 Jul, 2026, 15:29 IST.